Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study.

Autor: Jankovic J; Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology Baylor College of Medicine Houston Texas USA., Coffey B; Department of Psychiatry and Behavioral Sciences, Child and Adolescent Psychiatry University of Miami Miller School of Medicine Miami Florida USA., Claassen DO; Department of Neurology, Division of Behavioral and Cognitive Neurology Vanderbilt University Medical Center Nashville Tennessee USA., Jimenez-Shahed J; Movement Disorders Neuromodulation & Brain Circuit Therapeutics, Departments of Neurology and Neurosurgery Icahn School of Medicine at Mount Sinai New York New York USA., Gertz BJ; Nuvelution TS Pharma Inc. San Francisco California USA., Garofalo EA; Nuvelution TS Pharma Inc. San Francisco California USA., Stamler DA; Teva Branded Pharmaceutical Products R&D, Inc. La Jolla California USA., Wieman M; Teva Branded Pharmaceutical Products R&D, Inc. West Chester Pennsylvania USA., Savola JM; Teva Pharmaceuticals International GmbH Basel Switzerland., Harary E; Innovative Medicines, Global Clinical Development Teva Pharmaceutical Industries Ltd. Netanya Israel., Alexander J; Global Medical Affairs Teva Branded Pharmaceutical Products R&D, Inc. West Chester Pennsylvania USA., Barkay H; Innovative Medicines, Global Clinical Development Teva Pharmaceutical Industries Ltd. Netanya Israel., Gordon MF; Innovative Medicines, Global Clinical Development Teva Branded Pharmaceutical Products R&D, Inc. West Chester Pennsylvania USA.

Publikováno v: Movement disorders clinical practice [Mov Disord Clin Pract] 2023 Aug 24; Vol. 10 (9), pp. 1388-1398. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).

Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine.

Autor: Hauser RA; University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa, FL, USA. Electronic address: rhauser@usf.edu., Barkay H; Teva Pharmaceuticals, Netanya, Israel., Wilhelm A; Teva Pharmaceuticals, West Chester, PA, USA., Wieman M; Teva Pharmaceuticals, West Chester, PA, USA., Savola JM; Teva Pharmaceuticals International, Basel, Switzerland., Gordon MF; Teva Pharmaceuticals, West Chester, PA, USA.

Publikováno v: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2022 Apr; Vol. 97, pp. 47-51. Date of Electronic Publication: 2022 Mar 02.

Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.

Autor: Coffey B; University of Miami Miller School of Medicine, Miami, Florida., Jankovic J; Baylor College of Medicine, Houston, Texas., Claassen DO; Vanderbilt University Medical Center, Nashville, Tennessee., Jimenez-Shahed J; Icahn School of Medicine at Mount Sinai, New York, New York., Gertz BJ; Nuvelution TS Pharma Inc, San Francisco, California., Garofalo EA; Nuvelution TS Pharma Inc, San Francisco, California., Stamler DA; Teva Pharmaceuticals, La Jolla, California., Wieman M; Teva Pharmaceuticals, West Chester, Pennsylvania., Savola JM; Teva Pharmaceuticals, Basel, Switzerland., Gordon MF; Teva Pharmaceuticals, West Chester, Pennsylvania., Alexander JK; Teva Pharmaceuticals, West Chester, Pennsylvania., Barkay H; Teva Pharmaceuticals, Netanya, Israel., Harary E; Teva Pharmaceuticals, Netanya, Israel.

Publikováno v: JAMA network open [JAMA Netw Open] 2021 Oct 01; Vol. 4 (10), pp. e2129397. Date of Electronic Publication: 2021 Oct 01.

Evaluation of Analgesic Effect of Lidocaine Patch 5% in Post-herpetic Neuralgia: An Interventional Study.

Autor: AGGARWAL, PRIYANKA¹, REDHU, NEERAJ², JAISWAL, RAJMALA³ para3007@rediffmail.com, KATEWA, MANOJ KUMARI¹, GOYAL, TANU²

Publikováno v: Journal of Clinical & Diagnostic Research. Oct2024, Vol. 18 Issue 10, p10-14. 5p.

Vastgoedmanagement van winkelcentra en winkels

Autor: Janssen, I.I., Vermeer, B., Vermeulen, M., Wieman, M.

Publikováno v: Handboek Vastgoedmanagement, 144-161
STARTPAGE=144;ENDPAGE=161;TITLE=Handboek Vastgoedmanagement

In dit hoofdstuk worden aspecten belicht die vallen binnen de commerciële managementactiviteiten van een VMO, in de persoon van de commercieel manager. De commercieel manager is, als spin in het web, de eerstverantwoordelijke richting beleggingsorga

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::8d97c63ddb7bc370ff5128c653fd1688
https://research.tue.nl/nl/publications/b89b7fd7-7ee7-4080-a844-599a7391572e